Aw Zuardi

Summary

Country: Brazil

Publications

  1. ncbi Burden and stress among psychiatry residents and psychiatric healthcare providers
    Antonio Waldo Zuardi
    Dept of Neuroscience and Behavior, University of Sao Paulo, Sao Paulo, Brazil
    Acad Psychiatry 35:404-6. 2011
  2. ncbi Is the highest density of CB1 receptors in paranoid schizophrenia a correlate of endocannabinoid system functioning?
    Antonio Waldo Zuardi
    Department of Neurosciences and Behavior, Division of Psychiatry, Faculdade de Medicina de Ribeirao Preto, Universidade de Sao Paulo, Hospital das Clínicas Terceiro Andar, Av Bandeirantes, 3900, Ribeirao Preto, Sao Paulo, CEP 14049 800, Brazil
    Expert Rev Neurother 11:1111-4. 2011
  3. ncbi Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action
    Antonio Waldo Zuardi
    Department of Neurology, Psychiatry and Medical Psychology, Faculdade de Medicina de Ribeirao Preto, Universidade de Sao Paulo, Ribeirao Preto, SP, Brazil
    Rev Bras Psiquiatr 30:271-80. 2008
  4. ncbi Cannabidiol was ineffective for manic episode of bipolar affective disorder
    Aw Zuardi
    Department of Neuropsychiatry and Medical Psychology, Faculty of Medicine, University of Sao Paulo, Ribeirao Preto, Sao Paulo, Brazil
    J Psychopharmacol 24:135-7. 2010
  5. ncbi Cannabidiol for the treatment of psychosis in Parkinson's disease
    A W Zuardi
    Department of Neuropsychiatry and Medical Psychology, Ribeirao Preto Medical School, University of Sao Paulo, Sao Paulo, Brazil
    J Psychopharmacol 23:979-83. 2009
  6. ncbi Reduction of the anxiety of medical students after curricular reform
    Antonio Waldo Zuardi
    Department of Neurology, Psychiatry and Medical Psychology, Medical School, Universidade de Sao Paulo, Ribeirao Preto, SP, Brazil
    Rev Bras Psiquiatr 30:136-8. 2008
  7. ncbi History of cannabis as a medicine: a review
    Antonio Waldo Zuardi
    Department of Neurology, Psychiatry and Medical Psychology, Faculdade de Medicina de Ribeirao Preto, Universidade de Sao Paulo, SP, Brazil
    Rev Bras Psiquiatr 28:153-7. 2006
  8. ncbi Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug
    A W Zuardi
    Departamento de Neurologia, Psiquiatria e Psicologia Medica, Faculdade de Medicina de Ribeirao Preto, Universidade de Sao Paulo, Ribeirao Preto, SP, Brazil
    Braz J Med Biol Res 39:421-9. 2006
  9. ncbi Total agenesis of the corpus callosum in a patient with childhood-onset schizophrenia
    Jaime Eduardo Cecilio Hallak
    Department of Neurology, Psychiatry and Psychological Medicine, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, SP, Brazil
    Arq Neuropsiquiatr 65:1216-9. 2007
  10. ncbi Cavum septum pellucidum and adhesio interthalamica in schizophrenia: an MRI study
    José Alexandre de Souza Crippa
    Department of Neuropsychiatry and Medical Psychology, Faculty of Medicine, University of Sao Paulo, Ribeirao Preto, Sao Paulo, Brazil
    Eur Psychiatry 21:291-9. 2006

Collaborators

Detail Information

Publications19

  1. ncbi Burden and stress among psychiatry residents and psychiatric healthcare providers
    Antonio Waldo Zuardi
    Dept of Neuroscience and Behavior, University of Sao Paulo, Sao Paulo, Brazil
    Acad Psychiatry 35:404-6. 2011
    ..The authors compared the levels of job burden and stress in psychiatry residents with those of other healthcare professionals at inpatient and outpatient psychiatric hospitals in a medium-sized Brazilian city...
  2. ncbi Is the highest density of CB1 receptors in paranoid schizophrenia a correlate of endocannabinoid system functioning?
    Antonio Waldo Zuardi
    Department of Neurosciences and Behavior, Division of Psychiatry, Faculdade de Medicina de Ribeirao Preto, Universidade de Sao Paulo, Hospital das Clínicas Terceiro Andar, Av Bandeirantes, 3900, Ribeirao Preto, Sao Paulo, CEP 14049 800, Brazil
    Expert Rev Neurother 11:1111-4. 2011
    ..The precise role of the endocannabinoid system in the pathophysiology of schizophrenia remains far from understood...
  3. ncbi Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action
    Antonio Waldo Zuardi
    Department of Neurology, Psychiatry and Medical Psychology, Faculdade de Medicina de Ribeirao Preto, Universidade de Sao Paulo, Ribeirao Preto, SP, Brazil
    Rev Bras Psiquiatr 30:271-80. 2008
    ..The aim of this review is to describe the historical development of research on cannabidiol...
  4. ncbi Cannabidiol was ineffective for manic episode of bipolar affective disorder
    Aw Zuardi
    Department of Neuropsychiatry and Medical Psychology, Faculty of Medicine, University of Sao Paulo, Ribeirao Preto, Sao Paulo, Brazil
    J Psychopharmacol 24:135-7. 2010
    ..Both patients tolerated CBD very well and no side-effects were reported. These preliminary data suggest that CBD may not be effective for the manic episode of BAD...
  5. ncbi Cannabidiol for the treatment of psychosis in Parkinson's disease
    A W Zuardi
    Department of Neuropsychiatry and Medical Psychology, Ribeirao Preto Medical School, University of Sao Paulo, Sao Paulo, Brazil
    J Psychopharmacol 23:979-83. 2009
    ..No adverse effect was observed during the treatment. These preliminary data suggest that CBD may be effective, safe and well tolerated for the treatment of the psychosis in PD...
  6. ncbi Reduction of the anxiety of medical students after curricular reform
    Antonio Waldo Zuardi
    Department of Neurology, Psychiatry and Medical Psychology, Medical School, Universidade de Sao Paulo, Ribeirao Preto, SP, Brazil
    Rev Bras Psiquiatr 30:136-8. 2008
    ....
  7. ncbi History of cannabis as a medicine: a review
    Antonio Waldo Zuardi
    Department of Neurology, Psychiatry and Medical Psychology, Faculdade de Medicina de Ribeirao Preto, Universidade de Sao Paulo, SP, Brazil
    Rev Bras Psiquiatr 28:153-7. 2006
    ..A new and more consistent cycle of the use of cannabis derivatives as medication begins, since treatment effectiveness and safety started to be scientifically proven...
  8. ncbi Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug
    A W Zuardi
    Departamento de Neurologia, Psiquiatria e Psicologia Medica, Faculdade de Medicina de Ribeirao Preto, Universidade de Sao Paulo, Ribeirao Preto, SP, Brazil
    Braz J Med Biol Res 39:421-9. 2006
    ..Future studies of CBD in other psychotic conditions such as bipolar disorder and comparative studies of its antipsychotic effects with those produced by clozapine in schizophrenic patients are clearly indicated...
  9. ncbi Total agenesis of the corpus callosum in a patient with childhood-onset schizophrenia
    Jaime Eduardo Cecilio Hallak
    Department of Neurology, Psychiatry and Psychological Medicine, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, SP, Brazil
    Arq Neuropsiquiatr 65:1216-9. 2007
    ..The presence of schizophrenia with very early onset on absence of corpus callosum offers an opportunity to examine neurodevelopmental model and theories regarding to interhemispheric communication in the pathogenesis of psychosis...
  10. ncbi Cavum septum pellucidum and adhesio interthalamica in schizophrenia: an MRI study
    José Alexandre de Souza Crippa
    Department of Neuropsychiatry and Medical Psychology, Faculty of Medicine, University of Sao Paulo, Ribeirao Preto, Sao Paulo, Brazil
    Eur Psychiatry 21:291-9. 2006
    ....
  11. ncbi Cannabidiol monotherapy for treatment-resistant schizophrenia
    Antonio Waldo Zuardi
    Department of Neuropsychiatry and Medical Psychology, Faculty of Medicine, , , , Brazil
    J Psychopharmacol 20:683-6. 2006
    ..All patients tolerated CBD very well and no side effects were reported. These preliminary data suggest that CBD monotherapy may not be effective for TRS...
  12. ncbi Accuracy of psychiatric diagnosis performed under indirect supervision
    Cristina Marta Del-Ben
    Department of Neurology, Psychiatry and Medical Psychology, Clinical Hospital, Faculty of Medicine of Ribeirao Preto, Sao Paulo University, Brazil
    Rev Bras Psiquiatr 27:58-62. 2005
    ..63) was good. Systematic training of supervisors and residents in operational diagnostic criteria increased the accuracy of psychiatric diagnoses elaborated under indirect supervision, although excellent reliability was not achieved...
  13. ncbi [Social performance expectations in psychiatric patients of a general hospital ward]
    Maria Stela Setti Moreira
    Departamento de Neurologia, , , , , SP, Brasil
    Rev Saude Publica 36:734-42. 2002
    ..The average level of performance was unchanged throughout the first year after discharge, although demographic and medical variables can influence these results...
  14. ncbi Clozapine monotherapy for catatonic schizophrenia: should clozapine be the treatment of choice, with catatonia rather than psychosis as the main therapeutic index?
    Serdar Murat Dursun
    J Psychopharmacol 19:432-3. 2005
  15. ncbi [Brain effects of cannabis--neuroimaging findings]
    José Alexandre Crippa
    Departamento de Neurologia, Psiquiatria e Psicologia Medica, Faculdade de Medicina de Ribeirao Preto, Universidade de Sao Paulo, Brazil
    Rev Bras Psiquiatr 27:70-8. 2005
    ..Better designed neuroimaging studies, combined with cognitive evaluation, may be elucidative on this issue...
  16. ncbi Proton magnetic resonance spectroscopy of the frontal lobe in schizophrenics: a critical review of the methodology
    Rafael Faria Sanches
    Department of Neuropsychiatry and Medical Psychology, Faculty of Medicine of Ribeirao Preto, University of Sao Paulo, Sao Paulo, SP, Brazil
    Rev Hosp Clin Fac Med Sao Paulo 59:145-52. 2004
    ..Overall, studies that fulfill strict methodological criteria show N-acetyl aspartate decrease in the frontal lobe of male schizophrenics...
  17. ncbi Electrodermically nonresponsive schizophrenia patients make more errors in the Stroop Color Word Test, indicating selective attention deficit
    Eleomar Ziglia Lopes-Machado
    Departamento de Neurologia, Psiquiatria e Psicologia Medica, Faculdade de Medicina, Ribeirao Preto Medical School, Sao Paulo, Brazil
    Schizophr Bull 28:459-66. 2002
    ..These results suggest that there is a homogeneous subgroup of schizophrenia patients characterized by low neurovegetative responsiveness to external stimuli, predominance of negative symptoms, and selective attention deficit...